CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Itepekimab (SAR440340)

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
SNYPhase 3
✓Completed

Itepekimab (SAR440340) Phase 3 Est. Readout

Itepekimab (SAR440340)
Sep 2026~
CT.gov
Competitive Landscape

0 competitors in Chronic Obstructive Pulmonary Disease

View Full Landscape
Drug Information

Target Indication

Chronic Obstructive Pulmonary Disease

Clinical Trial

NCT06208306

Last updated: 12/13/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.